Home Trials Genes Drugs 23andMe Graph Blog Contact

Home
Trials
Genes
Drugs
23andMe
Graph
Blog
Contact

Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

ClinicalTrials.gov
OpenTargets
ClinVar
PubChem

Links

Contact
About
Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer”

4 trials

Filters

Phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Status

Recruiting

Active, Not Recruiting

Not Yet Recruiting

Completed

Enrolling by Invitation

Showing 4 of 4 results

Testing effectiveness (Phase 2)Looking for participantsNCT04802759

What this trial is testing

A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

Who this might be right for

Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer

Hoffmann-La Roche 316

Large-scale testing (Phase 3)Ended earlyNCT00925548

What this trial is testing

STRIDE - STimulating Immune Response In aDvanced brEast Cancer

Who this might be right for

Testing effectiveness (Phase 2)Study completedNCT01142401

What this trial is testing

Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer

Who this might be right for

Metastatic Breast CarcinomaStage IIIB Breast Cancer AJCC v7Stage IIIC Breast Cancer AJCC v7+1 more

National Cancer Institute (NCI) 118

Testing effectiveness (Phase 2)Study completedNCT03839823

What this trial is testing

Study to Compare the Combination of Ribociclib Plus Goserelin Acetate With Hormonal Therapy Versus Combination Chemotherapy in Premenopausal or Perimenopausal Patients With Advanced or Metastatic Breast Cancer

Who this might be right for

Novartis Pharmaceuticals 222